Envoy Medical (NASDAQ:COCH – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.27) EPS for the quarter, missing the consensus estimate of ($0.24) by ($0.03), Zacks reports. The business had revenue of $0.07 million during the quarter, compared to the consensus estimate of $0.08 million.
Envoy Medical Trading Down 4.4 %
Shares of COCH stock opened at $2.58 on Wednesday. Envoy Medical has a 1 year low of $0.75 and a 1 year high of $11.72. The firm’s 50 day moving average is $2.33 and its 200-day moving average is $3.31.
Analyst Upgrades and Downgrades
Separately, Ascendiant Capital Markets assumed coverage on Envoy Medical in a report on Monday, June 24th. They set a “buy” rating and a $8.50 price objective on the stock.
Envoy Medical Company Profile
Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.
Further Reading
- Five stocks we like better than Envoy Medical
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Chipotle Mexican Grill: Take a Bite of This Smoking Hot Deal
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Why O’Reilly Automotive Stock Could Be a Long-Term Winner
- Most active stocks: Dollar volume vs share volume
- Hut 8 Corp.’s Earnings: Is Crypto Mining About to Change?
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.
